Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression

Mathias Jachs(Medical University of Vienna), Péter Ferenci, Stephan W. Aberle(Medical University of Vienna), Marlene Panzer(Innsbruck Medical University), Lukas Hartl(Medical University of Vienna), Jeremy V. Camp(Medical University of Vienna), Petra Munda(Medical University of Vienna), Thomas Reiberger(Harvard University), Michael Trauner(Medical University of Graz), Heinz Zoller(Universität Innsbruck), Mattias Mandorfer(Medical University of Vienna), Lorenz Balcar(Paracelsus Medical University), Michael Schwarz(Medical University of Vienna)
JHEP Reports
April 7, 2023
10.1016/j.jhepr.2023.100751
Cited by 27

Related Papers

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
|Hepatology|2014|2k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
ESPEN Guidelines on Enteral Nutrition: Liver disease
|Clinical Nutrition|2006|683
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561